Table 1 Baseline Demographic and Clinical Characteristics of 346 febrile adult patients admitted to BMC, June – December 2011
CHARACTERISTIC | Proportion (%) or Median (IQR) |
|---|---|
Sex | |
Male | 179 (51.7%) |
Female | 167 (48.3%) |
Age in years | 35 (25 – 48) |
Marital status | |
Never Married | 100 (28.9%) |
Married | 160 (46.2%) |
Divorced | 41 (11.8%) |
Widow | 45 (13.1%) |
Body Temperature in degrees Celcius | 38.5 (38 – 39) |
Heart Rate in bpm | 111 (100–120) |
Respiratory Rate in bpm | 24 (22–32) |
Glascow Coma Score | 15 (15 – 15) |
WBC (x10 9 cells/mL) | 9.8 (4.6 – 14.2) |
Platelets (cells/mL) | 210 (137 – 312) |
Haemoglobin (g/dl) | 8.6 (6.3 – 10.8) |
HIV Status | |
Positive | 156 (45.1%) |
Negative | 190 (54.9%) |
CD4 count for 156 HIV-positive | 78 (38–129) |
Baseline WHO Clinical Stage for 156 HIV-positive | |
WHO clinical stage one | 0 (0.0%) |
WHO clinical stage two | 2 (1.3% |
WHO clinical stage three | 42 (26.9%) |
WHO clinical stage four | 112 (71.8%) |
ART Use among 156 HIV-positive | |
Yes | 48 (30.8%) |
No | 108 (69.2%) |
Type of ART patients used by 48 HIV-positive patients on ART | |
Atripla | 19 (39.6%) |
AZT/3TC/EFV | 11 (22.9%) |
Trioimmune | 5 (10.4%) |
Combivir/EFV | 8 (16.7%) |
Duovir - N | 1 (2.1%) |
Truvada - N | 1 (2.1%) |
ABC/DDI/Lpr/r | 2 (4.2%) |
D4T/3TC/Alluvia | 1 (2.1%) |